Baxter (NYSE:BAX) said today that it inked a collaborative deal with the Mayo Clinic to develop a new renal care center of excellence in the US.
The new renal care center will be located at the Mayo Clinic’s dialysis center in Jacksonville, Fla., Baxter said, and will integrate Baxter’s Renal Care Services clinical service model and CKD management system.
The center will look to serve patients across the “continuum of renal care,” Baxter said, from chronic kidney disease management through to transplants.
“The collaboration between Mayo Clinic and Baxter combines the best of our clinical, research and innovation expertise, and is rooted in the shared goal to improve the way we care for patients with serious and complex illnesses. We are excited to establish this new renal care center of excellence with Baxter,” Florida Mayo Clinic CEO Dr. Gianrico Farrugia said in a press release.
Through the collaboration, Deerfield, Ill.-based Baxter said it will also have the opportunity to test new, co-developed products and services with the Mayo Clinic
“We firmly believe there is a path to better care for kidney patients, which starts by managing the disease before dialysis is required and through simpler, more effective innovations. Our collaboration with Mayo Clinic will allow us to go even further in helping to establish transformative care,” Baxter renal care biz GM Laura Angelini said in a prepared statement.
Last month, Baxter said that it won FDA clearance for its Altapore bioactive bone graft, indicated for use as an autograft extender in posterolateral spinal fusion.
